Bullish Divergence on RSI and MACD Signals $INJ Is Set for a Major Move

Bullish divergence appears on both RSI and MACD, signaling underlying momentum and indicating potential reversal in $INJ’s multi-month price trend.

Injective trades above key support levels, with analysts eyeing $16 targets as structure break and fair value gap reactions confirm bullish continuation.

Canary Capital’s SEC filing for a staked Injective ETF offers traditional investors yield exposure and strengthens Injective’s DeFi to TradFi bridge.

Injective ($INJ) is attracting increased attention from traders and institutions as technical indicators flash early signs of a potential trend reversal. Backed by strong momentum and fresh institutional developments, INJ is trading at $14.93 after a 9.73% 24-hour gain as of writing.

Technical Indicators Signal Strength

Prominent crypto analyst CryptoBusy highlighted a strong bullish divergence on both the RSI and MACD indicators. According to the tweet, the Relative Strength Index (RSI) has formed higher lows since mid-2022. Meanwhile, price action continued forming lower lows through early 2025. This divergence is often observed when downward pressure weakens and bullish momentum begins to build.

On the MACD, the signs appear even more convincing. The MACD line, along with the histogram, is curving upwards. Both are now forming rising lows and pushing toward a bullish crossover. Historically, such movements across both indicators together often precede sharp directional changes in price. This alignment is viewed by many traders as a positive signal, especially when confirmed by multiple tools.

Structure Break and Fair Value Gap Reactions

Another analyst, DecyX, noted $INJ is showing strength following a confirmed Market Structure Shift (MSS). The token held above the key support range between $14.50 and $14.80. Price is now reacting positively after filling a fair value gap (FVG), suggesting renewed buying interest.

Source : DecyX

According to the tweet, if $INJ maintains strength above this zone, a continuation toward the $16 mark becomes increasingly probable. However, a healthy retracement into unfilled FVGs below $13 could offer long-term bulls a high-reward entry. These technical setups reflect how smart money often positions ahead of trend continuation.

INJ’s 7-day gain of 19.54% reinforces the bullish case. With price reclaiming crucial zones and buyers stepping in at logical levels, traders are monitoring for a decisive follow-through.

Institutional Catalyst: Staked $INJ ETF Filed in the U.S.

On the institutional front, a major development has surfaced. As per Mary_INJ, Canary Capital has filed with the SEC to launch the first-ever U.S.-staked Injective ETF. This product differs from traditional ETFs by staking the underlying $INJ tokens.

Investors will potentially earn rewards while contributing to Injective’s network security. Most importantly, this will happen via traditional banking and brokerage platforms, bridging DeFi and TradFi. The filing positions Injective among a small group of projects with exposure to regulated U.S. financial markets.

This institutional initiative adds weight to the ongoing narrative around Injective’s growing adoption. As developments in traditional finance begin to align with on-chain strength, market participants are watching Injective’s next move with interest.

With rising volume, technical confirmation, and institutional support converging, Injective appears poised for further momentum in the short to medium term.

The post Bullish Divergence on RSI and MACD Signals $INJ Is Set for a Major Move appears on Crypto Front News. Visit our website to read more interesting articles about cryptocurrency, blockchain technology, and digital assets.